Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCT00044
2005-09-08
Retrospective
Nil
N/a
n/a
Prof. Clement CY Tham
Dept. of Ophthalmology & Visual Sciences, Hong Kong Eye Hospital
2855 3788
Prof. Clement CY Tham
Dept. of Ophthalmology & Visual Sciences, Hong Kong Eye Hospital
2855 3788
2. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract.
Yes
2005-03-18
Eye Diseases
Procedure
Cataract extraction
30 to 45 minutes
Trabeculectomy
Inclusion Criteria 1. Eyes with CACG as defined above 2. No significant cataract: VA better than 20/40, and not affecting activities of daily living 3. Patient able and willing to give informed consent to phacoemulsification or trabeculectomy, prior to randomization Exclusion criteria 1. Single functional eye 2. Eyes with very advanced glaucomatous damage, defined as visual field loss threatening fixation, or cup-to-disc ratio of 0.9 and above 3. Patients refusing either cataract extraction or trabeculectomy 4. Previous intraocular surgery, with the exception of laser peripheral iridotomy and argon laser peripheral iridoplasty (ALPI).
Randomized
Active
Open label
Parallel
2005-03-18
30
Recruiting
IOP
1. Number of IOP-lowering medications 2. Anesthetic method required, anesthetic complications, and subjective pain score by visual-analog scale 3. Peri-operative complications 4. Operative time, and Total operative time (including second-staged trabeculectomy performed for phaco-alone patients whose IOP is not sufficiently controlled, any other additional glaucoma procedures to further control IOP, and any procedures to handle complications of surgery) 5. Visual acuity (VA) 6. Angle status by indentation gonioscopy and ultrasound biomicroscopy (UBM) 7. Change in visual field by automated perimetry (Humphrey¡¦s) 8. Change in vertical cup-to-disc ratio of the optic nerve head 9. Rate of aqueous outflow by pneumatonometer measurements 10. Quality of Life (QOL) 11. Cost-effective analysis ¡V including any additional procedures required to control IOP and cost of glaucoma drugs
2012-04-26
Yes
None
|
|
|
|
|
---|---|---|---|---|
No documents yet. |